NYSE - Nasdaq Real Time Price • USD
Evolent Health, Inc. (EVH)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:03 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | 0.23 | 0.27 | 1.16 | 1.63 |
| Low Estimate | 0.1 | 0.14 | 0.62 | 1.2 |
| High Estimate | 0.34 | 0.37 | 1.64 | 2.4 |
| Year Ago EPS | 0.21 | 0.14 | 0.87 | 1.16 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 14 |
| Avg. Estimate | 600.28M | 606.64M | 2.47B | 2.85B |
| Low Estimate | 595.82M | 596.82M | 2.42B | 2.7B |
| High Estimate | 605.08M | 632.89M | 2.6B | 3.05B |
| Year Ago Sales | 427.69M | -- | 1.96B | 2.47B |
| Sales Growth (year/est) | 40.40% | -- | 25.60% | 15.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.2 | 0.11 | 0.07 | 0.15 |
| EPS Actual | 0.21 | 0.14 | 0.3 | 0.23 |
| Difference | 0.01 | 0.03 | 0.23 | 0.08 |
| Surprise % | 5.00% | 27.30% | 328.60% | 53.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.23 | 0.27 | 1.16 | 1.63 |
| 7 Days Ago | 0.23 | 0.27 | 1.16 | 1.63 |
| 30 Days Ago | 0.23 | 0.27 | 1.16 | 1.63 |
| 60 Days Ago | 0.21 | 0.25 | 1.13 | 1.6 |
| 90 Days Ago | 0.22 | 0.25 | 1.13 | 1.6 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | EVH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 9.50% | -- | -- | 1.60% |
| Next Qtr. | 92.90% | -- | -- | 10.50% |
| Current Year | 33.30% | -- | -- | 5.20% |
| Next Year | 40.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 30.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 3/28/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 3/15/2024 |
| Initiated | Oppenheimer: Outperform | 3/1/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 2/23/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/23/2024 |
| Initiated | JMP Securities: Market Outperform | 12/6/2023 |
Related Tickers
PRVA Privia Health Group, Inc.
18.08
+1.46%
ACCD Accolade, Inc.
9.13
-0.44%
CMAX CareMax, Inc.
2.5700
+7.08%
RCM R1 RCM Inc.
11.99
-0.25%
HQY HealthEquity, Inc.
80.89
+1.30%
AGTI Agiliti, Inc.
10.04
0.00%
BTSG BrightSpring Health Services, Inc.
10.51
+2.14%
PGNY Progyny, Inc.
32.70
+2.57%
BEAT HeartBeam, Inc.
1.9300
-5.85%
PINC Premier, Inc.
21.18
+1.88%